Delivery is the Key
A new reality in genetic medicine lies ahead.
A reality where we can prevent or cure diseases by correcting the problem at the source.
The key is delivery: safe, effective and redosable nucleic acid delivery technology.
The Fusogenix PLV™ Platform
Enabling tomorrow’s genetic medicines today
The Fusogenix PLV platform uses our FAST fusion protein technology to enable delivery by direct fusion, allowing us to create genetic medicines that are safe, effective, and redosable.
Precision Targeting
Targeted delivery by FOCUS-AI and AIM
Our optimized platform leverages AI to enable highly targeted delivery of genetic medicines to organs, tissues and cells beyond the liver.
Pipeline and Partners
Enabling genetic cures for all
We develop precision nucleic acid therapies addressing key clinical unmet needs.
News and Publications
Stay up-to-date with the latest developments at Entos Pharmaceuticals.
Our Valued Partners
